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Abstract
The ribosome is an evolutionarily conserved organelle essential for cellular function. Ribosome construction requires
assembly of approximately 80 different ribosomal proteins (RPs) and four different species of rRNA. As RPs co-assemble into
one multi-subunit complex, mutation of the genes that encode RPs might be expected to give rise to phenocopies, in which
the same phenotype is associated with loss-of-function of each individual gene. However, a more complex picture is
emerging in which, in addition to a group of shared phenotypes, diverse RP gene-specific phenotypes are observed. Here
we report the first two mouse mutations (Rps7Mtu and Rps7Zma) of ribosomal protein S7 (Rps7), a gene that has been
implicated in Diamond-Blackfan anemia. Rps7 disruption results in decreased body size, abnormal skeletal morphology, mid-
ventral white spotting, and eye malformations. These phenotypes are reported in other murine RP mutants and, as
demonstrated for some other RP mutations, are ameliorated by Trp53 deficiency. Interestingly, Rps7 mutants have
additional overt malformations of the developing central nervous system and deficits in working memory, phenotypes that
are not reported in murine or human RP gene mutants. Conversely, Rps7 mouse mutants show no anemia or
hyperpigmentation, phenotypes associated with mutation of human RPS7 and other murine RPs, respectively. We provide
two novel RP mouse models and expand the repertoire of potential phenotypes that should be examined in RP mutants to
further explore the concept of RP gene-specific phenotypes.
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Introduction
Ribosomes are responsible for constructing the myriad proteins
required for the function of each individual cell. Ribosomes
themselves, which consist of small (40S) and large (60S) subunits,
are assembled from about 80 different ribosomal proteins (RPs)
along with four species of rRNA synthesized in the nucleolus [1,2].
RPs fall broadly into two categories; the RPL proteins that make
up the large ribosomal subunit, and the RPS proteins that
constitute the small subunit. Mutations in both RPL and RPS
genes have been implicated in a set of shared phenotypic
characteristics in invertebrates. This is best illustrated by the
approximately 50 Drosophila melanogaster Minute mutants, a collec-
tion of ribosomal gene mutations that are characterized by
developmental delay, short thin bristles, growth retardation,
reduced fertility and recessive lethality [3].
In vertebrates, a phenotypic overlap among RP mutants occurs
similar to that seen in Drosophila Minute mutants, however
additional phenotypic complexity is emerging, in which mutation
or suppression of RPs results in some phenotypes that depend
upon which gene is mutated. This is highlighted by a recent study
in which 20 different RP genes were targeted using morpholino
antisense oligos in the zebrafish Danio rerio [4]. Whereas some
phenotypes were shared among knockdowns, such as hypoplasia of
the yolk sac, others were gene-specific. For instance, knockdown of
rps15 resulted in an enlarged 4th ventricle of the brain, whereas
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knockdown of rpl35a caused a sharply bent tail, and targeting of
rps29 produced an enlarged lens [4]. A similar picture of
phenotypic overlap paired with gene-specific phenotypes is
emerging in mice. For example, mutations in Rps19 and Rps20
result in increased epithelial pigmentation, a ventral belly spot,
small body size, and a reduction in red blood cell count [5]. Mice
with mutations in Rpl24 also have ventral belly spots and body size
reduction, but they present with additional retinal abnormalities
and skeletal defects [6]. Mice harboring the Rpl27a sooty foot allele
share an epidermal hyperpigmentation phenotype with Rps19 and
Rps20 mutants, but display the additional feature of cerebellar
ataxia [7]. These distinct features of individual RP mutant
phenotypes suggest that vertebrate RPs may have unique, tissue-
specific functions and/or tissue-specific expression levels. Indeed,
the broad spectrum of distinct phenotypes that have been
characterized in a relatively small number of mammalian RP
mutants also hints at possible extra-ribosomal functions of RPs.
In humans, mutations in RPs have been implicated in
hematopoetic disorders, most notably Diamond-Blackfan anemia
(DBA), which has been attributed to mutations in RPS19, RPS26,
RPS24, RPS17, RPS10, RPS7, RPL35a, RPL26, RPL11, and RPL5
[8–14]. While anemia is a shared phenotype among all patients
carrying these various gene mutations, some specific attributes are
associated with individual genes. For example, mutations in RPL5
are associated with cleft palate and anomalies of the thumb and
heart, whereas isolated thumb malformations are predominant in
patients carrying mutations in RPL11 [11].
In this paper, we further examine the role of ribosomes in
mammalian development by investigating Rps7. Through analysis
of two new ENU-induced mouse mutants of Rps7, montu (Mtu)
and zuma (Zma), we show that mutation of Rps7 impairs ribosomal
biogenesis, resulting in variable lethality and reduced body size
accompanied by abnormal skeletal, melanocyte, eye, and central
nervous system (CNS) development. While many of these
phenotypes have previously been associated with mutation of
murine RP genes, the findings of overt brain malformations and
behavioral abnormalities are novel. Similar to mutation of other
RP genes in the mouse, the penetrance of the Rps7-associated
phenotypes is affected by genetic background and the overt
phenotypes are suppressed by TRP53 deficiency. These mutants
provide the first mouse models of Rps7 disruption and increase our
understanding of the phenotypic consequences of mammalian RP
mutations.
Results
Identification and genetic mapping of montu and zuma
The montu (Mtu) mouse was identified in a large-scale ENU
mutagenesis program [15,16] exhibiting dominant inheritance of a
ventral belly spot, kinked tail, and reduced body weight (Figure 1A,
1B). Linkage analysis was performed using a cross of the Mtu
founder (BALB/c OlaHsd background) with C3H/HeH. Analysis
of genotypes of 104 offspring demonstrated linkage to a 74 Mb
region of proximal chromosome 12 that was further refined to a
3.43 Mb critical region (Figure S1A, S1C). DNA sequencing of
exons and flanking regions of 17 candidate genes using genomic
DNA from four affected animals and controls identified a single
heterozygous sequence variant occurring only in affected mice
within exon 6 of Rps7, which encodes a 194 amino acid ribosomal
protein, RPS7 (or S7e, the eukaryotic specific homolog of the yeast
S7A and S7B). The identified Rps7 variant, c.574T.G
(NM_011300), encodes a Gly substitution of a highly conserved
Val residue (p.V156G; NP_035430) (Figure 1C, Figure S2A).
Subsequent sequence analysis of 91 animals from a C3H/HeH
congenic Mtu colony showed 100% concordance between the
c.574T.G mutation and the affected phenotypes. Analysis of Mtu
animals demonstrated variable penetrance on a mixed back-
ground, however 100% penetrance of the tail kink, belly spot, and
small body size phenotypes when assessed in the C3H/HeH
congenic colony. We also observed a dominant lethality phenotype
with incomplete penetrance, 72% viability in F1 BALB/c:C3H
mice (N = 251) and 26% viability in the C3H/HeH congenic
colony (N = 260).
The zuma (Zma) mouse was independently identified as part of a
sensitized ENU screen designed to identify mutations that
increased the severity of neural crest defects observed in Sox10
haploinsufficient mice (Sox10LacZ/+), a well characterized neural
crest mutant which presents with a high frequency of small, white
belly spots [17]. Affected backcross mice (BALB/cJ6C57BL/6J)
from the Zma pedigree exhibited large white belly spots, tail kinks,
and reduced body size. Linkage analysis of twelve affected N1
mice initially detected linkage of Zma to a region of chromosome
12 overlapping where the Mtu mutation was localized (Figure S1B,
S1C). Subsequent sequencing of Rps7 in Zma mice revealed a
heterozygous A to C point mutation in exon 7 of Rps7, predicted
to cause substitution of a conserved amino acid (p.Y177S;
c.637A.C) (Figure 1C, Figure S2A). Genotyping analysis of
Zma mice outcrossed to C57BL/6J to establish a congenic colony
showed that the c.637A.C mutation was observed in 100% of
affected mice. We initially observed incompletely penetrant
phenotypes in N2 heterozygous Zma mice on a mixed BALB/cJ;
C57Bl/6J background, where Zma/+ mice showed 74% viability,
76% belly spots, and 90% tail kinks (N = 46). However,
heterozygosity for the Zma allele rapidly changed to a completely
penetrant, lethal phenotype during outcrossing onto C57BL/6J,
and no Zma/+ mice were observed at N4. This contrasted with the
phenotype we observed during establishment of a congenic C3H/
HeJ Zma colony; on this genetic background, the N3 generation
exhibited a low frequency of belly spotting and tail kinks (4% and
0%, respectively; N = 41) yet no lethality, as Zma heterozygotes
Author Summary
Ribosomes are composed of two subunits that each
consist of a large number of proteins, and their function of
translating mRNA into protein is essential for cell viability.
Naturally occurring or genetically engineered mutations
within an individual ribosomal protein provide a valuable
resource, since the resulting abnormal phenotypes reveal
the function of each ribosomal protein. A number of
mutations recently identified in mammalian ribosomal
subunit genes have confirmed that homozygous loss of
function consistently results in lethality; however, haploin-
sufficiency causes a variety of tissue-specific phenotypes.
In this paper, we describe the first mutant alleles of the
gene encoding ribosomal protein S7 (Rps7) in mouse. Rps7
haploinsufficiency causes decreased size, abnormal skele-
tal morphology, mid-ventral white spotting, and eye
malformations, phenotypes that also occur with haploin-
sufficiency for other ribosomal subunits. Additionally,
significant apoptosis occurs within the developing central
nervous system (CNS) along with subtle behavioral
phenotypes, suggesting RPS7 is required for CNS devel-
opment. Mutation of human RPS7 has been implicated in
Diamond-Blackfan anemia (DBA), yet the murine alleles do
not present an analogous phenotype. The phenotypes we
observe in the Rps7 mouse mutants indicate RPS7 should
be considered as a candidate for a broader spectrum of
human diseases.
Rps7 Mouse Mutants
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were observed at the expected frequency through N6. The
comparably mild phenotype we observed in the congenic C3H/
HeJ Zma colony suggests that the Mtu allele may exert more severe
phenotypic effects than the Zma allele. This hypothesis is
supported by the observations that Mtu/+ mice presented with
reduced viability, fully penetrant belly spots, tail kinks, and small
body size on a predominantly C3H/He genetic background, while
Zma/+ mice on a similar background were observed at the
expected frequency and were generally indistinguishable in
phenotype from their+/+littermates.
Sequencing of exons 6 and 7 of Rps7 in 9 inbred strains (A/J,
AKR/J, BALB/c, C57BL6/J, C3H/HeJ, CBA, DBA, LP/J, and
101) confirmed that the point mutations detected in Mtu and Zma
are not natural variants. Additionally, we confirmed the presence of
the mutations in Rps7 transcripts using Mtu/+ and Zma/+ cDNA for
sequencing and real-time PCR, respectively. We also demonstrated
a lack of complementation between the Mtu and Zma Rps7 alleles by
performing an intercross of heterozygous mice from the two lines.
Genotyping of newborn offspring revealed that no animals carried
both the Mtu and Zma mutations (N = 27) (Figure S1D). The lack of
viable double heterozygotes was consistent with homozygote
lethality observed in each line, thus showing non-complementation
of the two alleles. Collectively, the similar phenotypes, sequencing
data, and genetic analyses provide strong evidence that the
mutations identified in Rps7 are responsible for the observed Mtu
and Zma phenotypes, hereafter referred to as Rps7Mtu and Rps7Zma.
Figure 1. Heterozygous mutation of Rps7 results in visible white spotting, small body size, and tail kinking. (A) Montu (Mtu)
heterozygous mice exhibiting a white belly spot and kinked tail were identified in an ENU mutagenesis screen. An independent ENU screen identified
zuma (Zma) mice with similar phenotypes (data not shown). (B) Heterozygote Mtu/+male (blue) and female (green) mice have a significantly reduced
body weight compared to wild-type male (gray) and female (red) littermates. (C) Sequencing revealed novel Rps7 point mutations in Mtu/+
(c.574T.G, encoding p.V156G) and Zma/+ (c.637A.C, encoding p.Y177S) mice. Sequence traces shown are for the antisense strand. Detailed Rps7
genomic structure information can be found at http://www.ncbi.nlm.nih.gov/gene/20115. (D) The predicted structural locations of mutated amino
acids in Rps7Mtu and Rps7Zma alleles. The three-dimensional structures of RPS7 orthologs from S. cerevisiae (PDB ID 3U5C_H, red) and T. thermophila
(PDB ID 2XZM_3, gray) are superimposed. The locations of the residues homologous to mouse p.V156 (*) and p.Y177 (arrow) are shown in green (S.
cerevisiae) and in yellow (T. thermophila). Image generated with UCSF Chimera.
doi:10.1371/journal.pgen.1003094.g001
Rps7 Mouse Mutants
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Functional analysis of the RPS7 mutations
The high degree of evolutionary conservation of both mutated
amino acids (p.V156G and p.Y177S) suggests that these alterations
may disrupt normal function. The consequences of the RPS7Mtu
and RPS7Zma mutant proteins were first assessed using the
computational analyses PANTHER and SIFT. Results from the
PANTHER coding SNP analysis tool [18] suggested that both
mutations are likely to be deleterious (PANTHER subPSEC score
of 25.00 and 25.06 for RPS7Mtu and RPS7Zma, respectively).
Similarly, the Sorting Tolerant From Intolerant (SIFT) algorithm
[19] predicted both alleles to affect protein function, however, the
high degree of conservation in the 72 database sequences at each
position resulted in a low confidence level for the prediction (SIFT
prediction score 0.00, median conservation 3.59 for both RPS7Mtu
and RPS7Zma). Collectively, the computational analysis was
consistent with the Rps7Mtu and Rps7Zma alleles both having
functional consequences.
The potential effects of p.V156G and p.Y177S on RPS7
secondary structure (Figure 1D, Figure S2) were also examined.
There is no three-dimensional protein structure currently available
for metazoan RPS7, therefore we used the available structures
from Tetrahymena thermophila (PDB ID 2XZM) and Saccharomyces
cerevisiae (PDB ID 3U5C), whose RPS7 ortholog sequences share
37% and 55% residue identity with mouse RPS7, respectively
[20,21]. RPS7 structural elements appear to be highly conserved
across species: the S. cerevisiae and T. thermophila proteins themselves
share only 34% amino acid identity, yet their solved three-
dimensional structures superimpose well, and are consistent with
secondary structural predictions of mouse RPS7 generated using
PSSpred (http://zhanglab.ccmb.med.umich.edu/PSSpred) and
PROFsec [22] (Figure S2B). Furthermore, the S. cerevisiae and T.
thermophila sequences each contain a Tyr residue homologous to
mouse p.Y177 (Figure S2A), and a Val residue homologous to
mouse p.V156 is present in S. cerevisiae and substituted conserva-
tively with Ile in T. thermophila. The introduction of either p.V156G
or p.Y177S into the mouse sequence did not alter predictions of
the beta strand and alpha helix at the respective locations of the
substitutions (Figure S2B), suggesting that grossly altered second-
ary structure may not be responsible for the functional
consequences of RPS7Mtu or RPS7Zma.
We next used biochemical analyses to examine the effects of
p.V156G and p.Y177S on stability and subcellular localization of
the 22 kiloDalton (kDa) protein as well as ribosome assembly and
biogenesis. Previous studies have shown that nonsense mutations
in RPS19 can result in decreased protein levels, and missense
mutations can alter the capacity of RPS19 to localize to the
nucleolus [23]. C- and N-terminal FLAG-tagged wild-type,
RPS7Mtu and RPS7Zma proteins were transiently expressed in
human embryonic kidney (HEK)-293 cells. Western blot analysis
revealed no differences in protein levels for any of the RPS7
mutant proteins (Figure 2A, Figure S3A). The remaining in vitro
studies were focused on the potentially more severe RPS7Mtu
mutant protein. Analysis of the FLAG-tagged proteins revealed no
notable differences in subcellular localization of the RPS7Mtu
protein (Figure 2B). To verify the capacity of RPS7Mtu to be
incorporated into the ribosome, cytoplasmic extracts from
transiently transfected HEK-293 cells were fractionated to
separate ribosomes and ribosomal subunits (in the pellet) from
free cytoplasmic proteins (in the supernatant). A similar fraction of
all transfected RPS7 proteins was observed in the ribosomal pellet
(Figure S3B) indicating that the mutation does not alter RPS7
assembly into the ribosome. To confirm this finding, cytoplasmic
extracts from Rps7Mtu/+ liver were analyzed by ultracentrifugation
through sucrose gradients, and the ratio between the peaks of the
ribosomal subunits in the absorbance profile was determined. This
ratio can reveal defects in the synthesis of one of the two subunits,
such as the net increase of the 60S/40S ratio seen in cultured
human cells following depletion of single RPs [24,25]. However,
the observed 60S/40S ratio in Rps7Mtu/+ liver was similar to
control (Figure S3C), indicating that RPS7Mtu does not drastically
alter assembly of the ribosomal subunits.
We further assessed whether RPS7Mtu affects ribosomal
biogenesis by analyzing the pre-rRNA maturation pattern.
Alterations are visualized by the accumulation of specific rRNA
precursors: a defect in large subunit RPs affects cleavage of 28S
precursors, whereas a defect in small subunit RPs alters that of 18S
precursors. Northern blot analysis of total RNA from wild-type
and Rps7Mtu/+ tissue, using a probe for the internal transcribed
spacer (ITS) 1 of pre-rRNA that anneals to 18S rRNA precursors
[26,27], indicated that 18S rRNA pre-rRNA processing was
altered both in liver and brain from Rps7Mtu/+ mutant mice
(Figure 2C). Quantitative measurement of the hybridization
signals showed a significant accumulation of the 30S precursor
in Rps7Mtu/+ (indicated by an increased 30S/21S ratio; Figure 2D),
confirming altered rRNA precursor processing and demonstrating
that the RPS7Mtu mutation has functional consequences on
ribosomal biogenesis.
Characterization of the Rps7 phenotype
Skeletal and eye malformation. X-ray examination of
adult Rps7Zma/+ mice showed that vertebral fusion is responsible
for the tail kinks (Figure 3A, 3B). Similar results were observed for
Rps7Mtu/+ adult mice, indicating that in both mutants, defective
somitogenesis occurs as a result of RPS7 alterations. Decreased
vertebrae numbers were also observed in both mutants; a
reduction in total vertebrae number in Rps7Mtu/+ (52–55 versus
55–57 in wild-type) and in caudal vertebrae number in Rps7Zma/+
(16–19 versus 20–22 in wild-type). The decreased vertebrae
numbers indicate defective tail bud function associated with
defects in RPS7. Alcian blue and alizarin red staining of late
gestation Rps7+/+ and Rps7Zma/+ embryos (N = 3 for each
genotype) revealed further Rps7Zma/+-associated skeletal abnor-
malities, including general disorganization of vertebral processes
and arches in the cervical vertebrae (Figure 3C, 3D). The anterior
tuberculum was appropriately located on C6, however a very
small partial rib was observed on C7 (in 2 Rps7Zma/+ embryos),
indicating an incompletely penetrant transformation of C7 to T1.
Within the thoracic region, we observed a shortened first
sternebrae and asymmetric attachment of 8 ribs to the sternum
rather than the usual 7 (in all 3 Rps7Zma/+ embryos) (Figure 3E,
3F). Within the lumbar and sacral regions, a severe developmental
delay was observed, and disorganization of the ossification centers
was evident with some ossification centers being duplicated
(Figure 3G, 3H). Additionally, we observed a transformation of
L1 to T13 (in all 3 Rps7Zma/+ embryos) and also asymmetric fusion
of the transverse processes of the first 5–6 sacral vertebrae (in 2
Rps7Zma/+ embryos) rather than the 3–4 observed in Rps7+/+
(Figure 3H). Collectively the skeletal phenotypes observed in Rps7
mutants are consistent with an anterior transformation of the axial
skeleton.
Frequent microphthalmia and uveal coloboma were also
observed as features of the Rps7 mutant phenotype (Figure 4).
Rps7Zma/+ embryos showed eye malformations ranging from
minor delay in optic fissure closure to severe microphthalmia and
internalization of the entire eye structure. Whole mount micro-
scopic imaging of E12.5 embryos revealed that 100% of Rps7Zma/+
embryos exhibited a unilateral or bilateral delay in closure of the
optic fissure, as compared to Rps7+/+ embryos which all showed
Rps7 Mouse Mutants
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normal optic fissures (N = 5 Rps7Zma/+, N = 7 Rps7+/+)
(Figure 4A–4C). By E14.5, a time when wild-type embryos have
complete fissure, 100% of Rps7Zma/+ embryos still displayed optic
fissure closure defects either unilaterally (N = 2) or bilaterally
(N = 3) (Figure 4D–4F). Additionally, more severe microphthal-
mia and internalization of the eye was observed in 20% of
Rps7Zma/+ embryos (Figure 4F, 4I; 1 out of 5 at both E12.5 and
E14.5).
Circulating blood chemistry and erythroid
differentiation. Because human RPS7 mutations are associated
with DBA [11], a disease characterized by red cell aplasia, we
undertook an initial characterization of circulating blood in adult
Rps7Mtu/+ mice (on a C3H/He background) and Rps7Zma/+ mice
(on a mixed C57BL/6J; BALB/cJ background). Neither Rps7
mutant allele caused any significant differences from Rps7+/+
littermates in total hemoglobin, red blood cell (RBC) counts, white
blood cell (WBC) counts, or hematocrit (Figure 5A, 5B, Table S1).
Mean corpuscular volume (MCV) was slightly elevated in Rps7Mtu/
+ mice (elevated 1.026 fold over wild-type, p,0.05) (Figure 5A),
however no significant difference in MCV was observed in
Rps7Zma/+ mice (Figure 5B). Additional analyses of plasma
biochemistry revealed no significant differences between
Rps7Mtu/+ and Rps7+/+ animals in major electrolytes and
metabolic indicators (Na+, K+, Cl2, urea, creatinine, ALP, AST,
ALT, total cholesterol, triglycerides, iron, amylase, and free fatty
acids) (Table S2).
To further assess erythroid development of Rps7Zma/+ mice,
which exhibit perinatal lethality on a C57BL/6J background,
E13.5 Rps7Zma/+ fetal liver samples were characterized by flow
cytometry. We simultaneously used monoclonal antibodies against
the erythroid cell lineage markers CD71, expressed at higher levels
during early stages of erythroid differentiation, and Ter119,
expressed at higher levels as erythrocytes mature, to profile 5
characteristic populations of erythroid precursors (R1 to R5)
[28,29] (Figure 5C). These cell populations correspond to
increasingly differentiated developmental stages, with R1 marking
erythroid progenitors and proerythroblasts, R2 marking proeryth-
roblasts and early basophilic erythroblasts, R3 marking all
basophilic erythroblasts, R4 marking chromatophilic and ortho-
chromatophilic erythroblasts, and R5 marking late orthochroma-
tophilic erythroblasts and reticulocytes. Compared to their Rps7+/
+ littermates, Rps7Zma/+ E13.5 embryos showed a significant
increase in the percentage of R3 cells (p,0.001) suggesting that
erythroid precursors could be blocked in their maturation
(Figure 5D). However, analysis of erythroid cell populations of
E14.5 fetal livers showed that the percentages of cells in the R2–
R5 populations were indistinguishable between Rps7+/+ and
Rps7Zma/+ genotypes (Table S3). The presence of the more mature
R4 and R5 cells at E14.5 indicates erythroid differentiation
progresses, rather than being blocked at R3. Alternatively, the
increase in R3 cells at E13.5 may result from a general
developmental delay in Rps7Zma/+ embryos. This was confirmed
by inspection of gross anatomical features of crown-rump length,
along with eye, limb, and craniofacial development at E11.5–13.5,
which showed that Rps7Zma/+ embryonic development is delayed
by approximately one day relative to that of Rps7+/+ littermates
(Figure S4). While we cannot rule out subtle alterations in
erythroid maturation that may cause the differences observed in
the precursor populations, these analyses collectively suggest that
these two mutant alleles of Rps7 do not significantly impair red
blood cell production or differentiation.
Early effect on melanoblast development. To assess the
effects of RPS7 mutation on melanocyte development, we
characterized Rps7Zma/+ mutant embryos from E10.5 to 14.5.
Figure 2. Rps7Mtu shows reduced function in ribosomal
precursor processing. (A) Western blot showing similar levels of
expression for N- and C-terminal FLAG-tagged wild-type RPS7 (WT-N
and WT-C, respectively) and RPS7Mtu (M-N and M-C, respectively)
proteins in HEK-293 cells. The RPS7-specific band is indicated by *, and
NPT2 (arrowhead) expression is shown as a control. (B) Subcellular
localization of N- and C-terminal FLAG-tagged RPS7 proteins. Wild-type
RPS7 and RPS7Mtu both localize to speckles in the nucleus and are
observed throughout the cytoplasm. Scale bar = 10 um. All panels are at
the same magnification. (C) Representative Northern blot analysis of
liver and brain RNA from wild-type (WT) and Rps7Mtu/+ (M) mice
detecting various rRNA precursors using a probe within the internal
transcribed spacer (ITS1). The 30S and 21S rRNA precursors are
indicated. (D) Quantitation of the signals of Northern experiments
reported as the ratio between 30S and 21S rRNA precursors was
significantly different between Rps7+/+ and Rps7Mtu/+ (* indicates
p,0.01). The average of the values is reported in the bar graphs with
S.E.M.
doi:10.1371/journal.pgen.1003094.g002
Rps7 Mouse Mutants
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To mark developing melanoblasts, we generated transgenic
Rps7Zma/+ embryos carrying the melanoblast reporter Tg(Dct-
LacZ) [30]. In these Rps7Zma/+; Tg(Dct-LacZ) embryos, Dct-positive
melanoblasts were notably reduced by E10.5 relative to Rps7+/+;
Tg(Dct-LacZ) littermates (Figure 6A, 6B). At E14.5, a significant
reduction in melanoblast number was still observed in both the
head and trunk of Rps7Zma/+; Tg(Dct-LacZ) mice compared to
Rps7+/+; Tg(Dct-LacZ) littermates (Figure 6C–6F). Mutation of
Rps7 did not cause a complete loss of melanoblasts, however, as
Dct-positive cells could still be observed at E14.5 in regions where
melanoblast density is normally highest, particularly around the
developing pinna and eye (Figure 6C, 6D). This severe melano-
blast reduction in Rps7Zma/+ embryos was independently con-
firmed by in situ hybridization with a probe targeting mRNA for
the melanoblast/melanosome-specific protein Pmel17 (Figure S5).
Qualitative observation of Pmel17-expressing melanoblasts showed
that E12.5 Rps7Zma/+ mutant embryos displayed a marked
reduction in melanoblasts relative to E12.5 Rps7+/+ littermates.
The reduction in melanoblasts is more severe than can be
attributed to the developmental delay observed in Rps7Zma/+
mutants, as E12.5 Rps7Zma/+ embryos showed a reduced
melanoblast number even in comparison to E11.5 Rps7+/+
embryos (Figure S5). A combination of Rps7 and Sox10
haploinsufficiency (Rps7Zma/+; Sox10LacZ/+ double heterozygotes)
further reduced melanoblast number at E12.5 (Figure S6),
consistent with the increased spotting observed in rare Rps7Zma/
+; Sox10LacZ/+ pups that survived postnatally (Figure S7A, S7B).
Postnatally, we observed that melanocytes were present in the
tail skin of Rps7Zma/+ mice (Figure S7E, S7F), yet no dark skin
phenotype occurred in the tails or footpads of adult Rps7Zma/+ or
Rps7Mtu/+mice (Figure S7C–S7F). This indicates that these Rps7
mutations do not cause epidermal melanocytosis, as was previously
observed for mutation of Rps19 and Rps20 [5]. Collectively, these
data show that mutation of Rps7 causes a severe, early reduction in
melanoblasts that is sufficient to account for the white belly
spotting observed in viable heterozygotes.
Enlarged ventricles, cortical thinning, and deficits in
working memory. We examined the neuroanatomical features
of the Rps7 mutants, employing histological techniques and
magnetic resonance microscopy (MRM). Gross observations and
histological staining revealed marked cortical thinning accompa-
nied by enlarged ventricles in adult Rps7Mtu/+ (Figure 7A–7B) and
perinatal Rps7Zma/+ mice (Figure 7C, and data not shown). To
investigate this phenotype further, we undertook MRM imaging of
Rps7Zma/+ mice at E18.5 (N = 3) (Figure 7D–7I). Following
manual segmentation of 10 major anatomic structures, the volume
of each brain region was calculated as a percentage of the total
brain volume (Figure 7J) and 3-dimensional (3D) rendering with
smoothing was performed to generate 3D representations (Video
S1 and Video S2). This quantitative analysis showed that the
Rps7Zma/+ CNS phenotypes originate during development and
confirmed a significant reduction in cortical (P = 0.0002) and
hippocampal (P = 0.0044) size in Rps7Zma/+ mutants. Although
lateral ventricle volume was not significantly different between
these small groups, qualitative observations of ventricle size at
dissection, in MRM images, and in histological sections consis-
tently indicated Rps7Zma/+ mutants had enlarged ventricles,
leading us to conclude that enlarged ventricles are a consistent
feature of the Rps7 phenotype.
We investigated whether these gross neuroanatomical pheno-
types affected the behavior of the Rps7Mtu/+ mice, assessing
locomotor activity, anxiety and working memory. The results
showed that while Rps7Mtu/+ mutants exhibited normal locomotor
activity and anxiety-related phenotypes, they displayed deficits in
Figure 3. Skeletal abnormalities in Rps7 mutants. (A, B)
Comparative X-rays of adult Rps7+/+ (A) and Rps7Zma/+ (B) mice show
severe vertebral fusion leading to tail kinking in an Rps7Zma/+ mutant.
(C–H) Alcian blue and alizarin red skeletal staining of late gestation
Rps7+/+ (C, E, G) and Rps7Zma/+ (D, F, H) embryos. (C, D) Disorganization
within the neural arches of Rps7Zma/+ is evident in a dorsal view of the
cervical vertebrae. (E, F) Asymmetric attachment of 8 ribs to the
sternum (arrow) and a shortened first sternebrae (*) are indicated in
Rps7Zma/+. (G, H) Delayed development and disorganization of the
ossification centers is apparent in the lumbar and sacral vertebrae. The
sacral vertebrae show abnormal fusing of additional vertebrae
(bracketed region). Scale bars: C,D,G,H= 2 mm; E,F = 200 mm.
doi:10.1371/journal.pgen.1003094.g003
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working memory. Rps7Mtu/+ mutants displayed similar behavior to
Rps7+/+ controls in an open-field test, with no significant
differences in total distance travelled in the open field or time
spent in the center (Figure S8A). Similarly, there were no
significant differences between Rps7+/+ controls and Rps7Mtu/
+littermates when assessed on the elevated plus-maze (Figure S8B–
S8E), nor did Rps7Mtu/+ mutant animals display any ataxia that
would be indicative of motor dysfunction. We also investigated
whether Rps7Mtu/+ mice displayed any defects in working memory
using a spontaneous alternation test, which can indicate hippo-
campal dysfunction [31]. The mouse is placed in the start arm of
an enclosed T-maze (the base of the ‘‘T’’), and allowed to enter a
goal arm (the two arms of the top of the ‘‘T’’) of its own choice.
Upon repeating this test, the mouse can demonstrate memory of
its previous choice by entering the arm not visited before, a
behavior called spontaneous alternation. Here we observed a
significant difference between Rps7+/+ controls, which exhibited
an average alternation frequency of 83%, and Rps7Mtu/+ mutants,
which exhibited an average alternation frequency of only 68%
(N = 9, P = 0.01) (Figure 7K). Collectively, the MRM and
behavioral data indicate that Rps7 is required for normal
development of the central nervous system, particularly the
telencephalon, and that mutations in this gene have the capacity
to affect hippocampal-dependent behavior.
Increased neuronal apoptosis in Rps7 mutants. Our
histological studies also revealed that late gestation Rps7Zma/+
embryos exhibited pyknotic nuclei in the white matter tracts of the
spinal cord (Figure S9), consistent with CNS degeneration. As
mutations in other RPs have been associated with increased
cellular apoptosis [32–37], we used immunohistochemistry to
detect cleaved caspase-3 (CC3) within the CNS. When compared
to normal littermates, Rps7Zma/+ embryos showed increased
apoptosis in the cortex and neural tube at both E11.5
(Figure 8A, 8B, 8D, 8E) and E12.5 (data not shown). Although
mitotic, phospho-histone H3-positive (PH3+) cells surrounding the
lumen of the neural tube appeared slightly disorganized in E11.5
and E12.5 Rps7Zma/+embryos (Figure 8G, 8H and data not
shown), cell counting revealed no significant difference in PH3+
cell number per section compared to Rps7+/+ littermates
(Figure 8J). In contrast, CC3 counts confirmed a significant
increase in apoptosis in the neural tube of E11.5 Rps7Zma/+
embryos compared to Rps7+/+ (N = 3, p,0.001) (Figure 8K).
Consistent with the location of apoptosis and with a putative role
for RPS7 in CNS development, in situ hybridization studies on
Figure 4. Eye dysmorphology in Rps7 mutants. Representative whole-mount images from one Rps7+/+ and two different Rps7Zma/+ embryos
are shown at E12.5 (A–C) and 14.5 (D–F). In addition, H&E stained sagittal sections through the eye are shown for one Rps7+/+ and two different
Rps7Zma/+ embryos at E18.5 (G–I). The eye dysmorphology of Rps7Zma/+mutants ranges in severity from minor unilateral or bilateral uveal coloboma
(E, H) to severe microphthalmia resulting in disorganized eye structures (C, F, I). Arrows in E and F mark examples of coloboma and extreme
microphthalmia, respectively. Arrow in H marks abnormal folding of the retinal layers. All images are oriented with anterior up, rostral to the right.
Within each age group/row, all genotypes are shown at the same magnification. Scale bars = 0.5 mm.
doi:10.1371/journal.pgen.1003094.g004
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Rps7+/+ embryos revealed that Rps7 is highly expressed in
proliferative regions, including the ventricular zone (Figure S10).
As TRP53 levels are altered in other ribosomal mutants, we also
investigated the expression of TRP53 in the developing CNS of
Rps7 mutants. Using immunohistochemistry, we observed an
increase in TRP53 staining in the cortex (E11.5) and neural tube
(E11.5 and E12.5) of Rps7 mutants consistent with increased
TRP53-mediated apoptosis (Figure S11). Collectively, the histol-
ogy and immunohistochemistry data confirm that massive cell
death in the Rps7 mutant CNS occurs at the onset of neurogenesis.
Phenotypic suppression of Rps7 mutant phenotypes
byTrp53 haploinsufficiency. In an attempt to restore hetero-
zygote viability by suppressing apoptosis, we crossed the Rps7Zma
mutation onto a Trp53 mutant background. Trp53 mutations have
been used to successfully suppress phenotypes in other RP mutants
[5,35]. Rps7Zma mice were originally identified on a mixed genetic
background, and heterozygote lethality in Rps7Zma/+ mice
increased as the mutation was outcrossed onto a C57BL/6J
background. Thus we used early generation, mixed background
Rps7Zma/+ mice to establish a cross with Trp53 mutant mice on a
C57Bl/6J background (B6.129S2-Trp53tm1Tyj/J, hereafter
Trp53KO). Within a few generations of outcrossing, no viable
Rps7Zma/+ mice were observed after birth, as expected. However,
Rps7Zma/+; Trp53 KO/+ double heterozygotes were recovered at
the expected 50% frequency, suggesting restoration of Rps7Zma/+
viability in the context of Trp53 haploinsufficiency (Table S4). In
Figure 5. Peripheral-blood parameters appear normal with slight developmental delay in Rps7Zma/+ fetal liver red cell precursors.
(A) Rps7Mtu/+ mice displayed similar complete blood count (CBC) values to their wild-type littermates with the exception of a very slightly elevated
mean corpuscular volume (MCV) (* indicates p,0.05; N= 7). (B) Rps7Zma/+ mice did not differ significantly from their wild-type littermates in any CBC
measurements (N = 5). (C) A typical example of FACS analysis of fetal liver cells. The 5 characterized erythroid cell populations, R1–R5, are boxed in
pink. (D) The average values and standard deviation for each fetal liver erythroid cell population are given as a percentage of total viable cells in
Rps7+/+ and Rps7Zma/+ samples (* indicates p,0.001; N = 6).
doi:10.1371/journal.pgen.1003094.g005
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addition to restoring viability, Trp53 mutation fully suppressed the
Rps7Zma-associated vertebral fusion phenotype that was observed
in earlier generations of Rps7Zma/+ mice (no tail kinks observed in
.25 Rps7Zma/+; Trp53KO/+ mice). In most cases Rps7Zma/+;
Trp53KO/+ double heterozygotes were indistinguishable from their
wild-type littermates after weaning, with the exception of a very
small belly spot observed in 47% of Rps7Zma/+; Trp53KO/+ mice.
Trp53 haploinsufficiency also suppressed the phenotypes of gross
embryonic developmental delay (Figure S4), the subtle delay in
erythroid maturation (Table S3), and CNS apoptosis (Figure 8C, 8F,
8K). In summary, the pleiotropic phenotypes observed in Rps7Zma/+
mice all appeared to be suppressed by Trp53 haploinsufficiency.
Discussion
In this paper we present genetic, functional, and phenotypic
evidence that the montu (Mtu) and zuma (Zma) mouse lines isolated
from independent ENU screens harbor distinct point mutations in
Rps7. These first-reported alleles of Rps7 in mice cause similar
phenotypes including small body size, tail abnormalities, mid-
ventral white spotting, eye defects, and an underdeveloped
cerebral cortex.
We provide functional evidence that the Rps7Mtu mutation
(p.V156G) affects ribosome biogenesis. The altered Rps7Mtu 30S/
21S ratio is consistent with the altered pre-rRNA maturation
reported for a DBA patient harboring an RPS7 donor splice-site
mutation (c.147+1G.A) that results in accumulation of 30S and
45S precursors [11]. A requirement for RPS7 during rRNA
maturation is supported by other studies showing a role for human
RPS7 in early stages of 45S rRNA processing [24] or the nuclear
stages of 40S maturation [38]. In yeast, depletion of the two RPS7
paralogs (S7a and S7b) results in a severe growth defect [39,40]
and S7 has been hypothesized to play an early role as a component
of the small subunit processome [41] as well as a later role in
ribosome biogenesis during assembly of polysomes [42]. However,
the mechanism underlying the altered rRNA maturation in these
murine Rps7 mutants is not clear, as neither the Rps7Mtu nor the
Rps7Zma mutation is predicted to grossly disrupt protein secondary
structure, and RPS7Mtu protein is correctly localized and
incorporated into ribosomes in cultured cells. Presumably, the
mutant RPS7 proteins could be altered in their interactions with
rRNA, other ribosomal proteins, or non-ribosomal proteins. The
possibility of interaction with non-ribosomal proteins is intriguing
given the position of RPS7 at the surface of the ribosome (Figure
S2C, S2D) in close proximity to the binding site for eIF4G [21], a
eukaryotic initiation factor important for assembling the pre-
initiation complex. Interestingly, most other known, viable mouse
RP mutations also occur in eukaryotic-specific RPs located at the
surface of the ribosome. Additional work is needed to determine
the precise role RPS7 plays in mammalian ribosome biogenesis
and how the Rps7Mtu and Rps7Zma mutations disrupt this function.
While modeling the pre-rRNA processing defect of an RPS7
DBA patient, these Rps7 mutant mice do not replicate the
characteristic DBA phenotype of severe anemia. This lack of an
anemia phenotype is not entirely unexpected, since the analysis of
many mouse mutants suggests that mice as a species are generally
less sensitive than humans to any gene haploinsufficiency [43,44].
This is exemplified by the fact that, despite frequent mutation of
Figure 6. Melanoblast numbers are reduced in Rps7Zma/+ mutants. (A, B) In transgenic embryos carrying the melanoblast reporter Tg(Dct-
LacZ), whole mount staining showed that Dct-positive melanoblasts are significantly reduced at E10.5 in Rps7Zma/+; Tg(Dct-LacZ) mice (A) compared
to Rps7+/+;Tg(Dct-LacZ) littermates (B). The reduction is noticeably apparent over the otic region (red circle). (C,D) Whole mount staining of E14.5
Rps7Zma/+; Tg(Dct-LacZ) embryos showed that these embryos (D) also display a reduction in melanoblasts relative to Rps7+/+;Tg(Dct-LacZ) littermates
(C). The microphthalmia observed in Rps7Zma/+ mice is apparent in (D). (E, F) Consistent with the whole-mount observations, transverse vibratome
sections through the trunk of E14.5 embryos revealed very few melanoblasts in the developing skin of Rps7Zma/+; Tg(Dct-LacZ) mice (F) as compared
to the numerous melanoblasts seen in Rps7+/+;Tg(Dct-LacZ) littermates (arrow, E). Blue punctate staining indicates positive signal in melanoblasts. In
all pairs of images, Rps7+/+ and Rps7Zma/+ are at the same magnification. NT =neural tube.
doi:10.1371/journal.pgen.1003094.g006
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Figure 7. Brain size and behavioral abnormalities in Rps7mutants. (A) A Nissl stained coronal section of a 5 month old Rps7Mtu/+brain shows
a thinner cortex and larger ventricles when compared to an Rps7+/+ littermate. (B, C) Dissected whole brains show that the cortex is reduced in size in
adult Rps7Mtu/+ (B) and postnatal day 0 Rps7Zma/+mice (C) when compared to Rps7+/+ littermates. (D–I) Magnetic Resonance Microscopy (MRM) was
used to visualize brain development in late gestation (E18.5) Rps7+/+(D–F) and Rps7Zma/+(G–I) embryos. Enlarged ventricles (v in panel H) were
apparent in all Rps7Zma/+ samples (N = 3). Representative slices are shown in sagittal (D,G), coronal (E,H), and axial (F,I) views. Scale bars = 1 mm. (J)
The volume of each brain region was quantitated as a percentage of total brain volume in Rps7+/+(black columns) and Rps7Zma/+(gray columns)
(N = 3). Abbreviations: Olfactory bulbs (OB), lateral ventricles (LV), cortex (Ct), septum (Sp), striatum (St), 4th ventricle (4V), hippocampus (Hp),
thalamus (Th), colliculi (Co), cerebellum (Ce). ** indicates p,0.005. (K) Assessment of working memory by measuring spontaneous alternation in a T-
maze showed a significant difference between Rps7Mtu/+mice and Rps7+/+ littermate controls (* indicates P = 0.01, N= 9). In all panels +/+= Rps7+/+;
Mtu/+= Rps7Mtu/+; Zma/+= Rps7Zma/+.
doi:10.1371/journal.pgen.1003094.g007
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RPS19 in DBA, Rps19 heterozygote knockout mice have been
described with normal hematopoiesis [34,45] and an ENU allele of
Rps19 displays only a mild erythrocyte phenotype, along with an
elevated MCV that parallels the slightly elevated MCV in Rps7Mtu
[5]. It is possible that further studies of Rps7 alleles on different
genetic backgrounds or in mice with more severe alleles may
reveal additional red blood cell phenotypes. In the future,
comparison among mouse DBA models may provide insight into
why the murine and human hematological phenotypes do not fully
overlap, and may also reveal why mutation in RPS19 has a
uniquely high frequency in DBA compared to other RPs that
cause the disease.
Both Rps7 mutants display a variety of skeletal phenotypes that
collectively suggest that normal ribosome biogenesis is required for
three distinct stages of somite development, which governs
subsequent axial skeleton formation. First, the decreased number
of tail vertebrae indicates an insufficient production of somite
progenitors. Second, the mutant vertebral fusion leading to tail
kinks is indicative of incorrect somite border formation. Third, the
mutants exhibit an array of axial skeleton defects consistent with
Figure 8. Increased apoptosis occurs in the developing CNS of Rps7Zma/+ mutant embryos; however, this apoptosis is reduced in
Rps7Zma/+; Trp53KO/+ embryos. (A–C) Increased apoptosis was observed in E11.5 Rps7Zma/+ (Z/+) coronal sections through the neocortex compared
to Rps7+/+ (+/+) and Rps7Zma/+; Trp53KO/+ (Z/+;p53/+), as measured by cleaved caspase-3 (CC3) staining shown in green. (D–F) Apoptosis was also
relatively increased in neural tube cross-sections of Rps7Zma/+ embryos at E11.5 (E). (G–I) Cellular disorganization was apparent in mitotic, phospho-
histone H3-positive (PH3+) cells surrounding the lumen of the neural tube in E11.5 Rps7Zma/+ embryos (H). (J) E11.5 Rps7Zma/+ (z) embryos showed no
difference from Rps7+/+(+) or Rps7Zma/+; Trp53KO/+(p) in total counts of PH3+ cells surrounding the lumen of the neural tube. (K) CC3+ cell counts
confirmed significantly increased apoptosis in E11.5 Rps7Zma/+ (z) neural tube as compared to Rps7+/+ (+) or Rps7Zma/+; Trp53KO/+ (p) (* indicates
p,0.001). Scale bars: in A, D, G = 100 mM with equivalent magnification across all genotypes.
doi:10.1371/journal.pgen.1003094.g008
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an anterior transformation, indicating that somite identity is
perturbed. Widespread disturbances of the skeletal system
encompassing each of these three defects are also found in Rpl38
(tail short, Ts) [46,47] and Rpl24 (belly spot and tail, Bst) mutants
[6,48]. Indeed, there are striking similarities in the defects
observed in Rpl38 and Rps7 mutants, including specific transfor-
mations within the cervical (C7 to T1), thoracic (T8 to T7), lumbar
(L1 to T13) and sacral (fusion of additional transverse processes)
regions. Mutations in Rpl38 and Rpl24 cause additional distur-
bances of the appendicular skeleton not observed in Rps7,
however, given the similarities of these mutants to Rps7 it will be
interesting to see if appendicular skeletal defects are observed with
different Rps7 alleles and/or genetic backgrounds. Interestingly,
severe skeletal malformations have not been reported for five other
murine RP mutants (Rps19, Rps20, Rpl22, Rpl27a, Rpl29)
[5,7,8,49,50]. This suggests that either mutation of RP proteins
do not universally affect skeletal development, or skeletal defects
remain to be identified in these other RP mutants. In the case of
Rps7, the severity of skeletal defects was modified by both genetic
background and by allele, suggesting that detailed characterization
in existing and additional RP mutants is necessary to further
explore the role of RP proteins in skeletal development.
We show that Rps7Zma-mediated white spotting results from a
severe developmental reduction in melanoblasts. A developmental
reduction in melanoblasts has also been reported in Rps19 and
Rps20 heterozygous mutants, however, these mutants subsequently
develop epidermal melanocytosis [5], a phenotype not seen in
either Rps7 mutant. This difference is unlikely to be due to genetic
background, as both Rps7 mutants and Rps19 and Rps20 mutants
were examined on a predominantly C3H background. Alterna-
tively, the difference could be a more severe developmental
reduction in melanoblast numbers in Rps7 mutants, resulting in
fewer melanoblasts available at later time points to generate
epidermal melanocytosis. Another possibility is that loss of Rps7
may not have the same effect in keratinocytes as loss of Rps6, Rps19
and Rps20, which are thought to act in keratinocytes to produce
TRP53-mediated dark skin [5]. Our in vitro experiments with Rps7
(Figure 2 and Figure S3) suggest that these mutations are
hypomorphic alleles, so a third possibility is that allele severity,
rather than gene-specific function, could account for pigmentation
phenotype differences among RP mutants.
The mouse Rps7 mutants display additional developmental
defects of reduced cortical and hippocampal size. We hypothesize
that cell death within the developing CNS is sufficient to account
for the neocortical thinning we observe in both Rps7 mutant lines.
We also hypothesize that apoptosis within the developing
telencephalon might account for the deficit in working memory
observed in Rps7Mtu/+ heterozygotes. To our knowledge, this is a
novel developmental brain abnormality in mouse arising from RP
haploinsufficiency, differing substantially from the only other
report of neuronal defects in RP mutant mice, that of cerebellar
abnormalities and ataxia in Rpl27a sooty foot mutants [7].
Interestingly, the neuronal phenotypes in mouse Rps7 mutants
correlate with the report of microcephaly as one of 11 congenital
craniofacial anomalies that can be associated with DBA [51], and
are consistent with RP mutant phenotypes observed in different
model organisms. In zebrafish, gene-specific neuronal phenotypes
were seen in a subset of knocked-down RPs [4] and further studies
of RPL11 revealed brain deformities and reduced neuronal
progenitor cells along with apoptosis in the affected regions [32].
In the zebra finch, RPL17 and RPL37 both regulate the sexually
dimorphic formation of the song control regions of the brain
within the VZ [52]. Thus, the murine Rps7 mutant phenotypes
add to a growing body of literature linking individual RPs to
specific features of neural development and suggesting that other
RP mouse mutants may have previously uncharacterized defects in
brain development.
Important questions remain regarding what underlying cellular
mechanisms explain the similarities and differences among RP-
associated phenotypes. A growing body of literature suggests a
common mechanism where alterations in RP expression result in
activation of TRP53, suggesting ribosomal stress is one of the
many cellular anomalies detected by TRP53. For example, in their
study of RP-mediated dark skin, McGowan and colleagues show
that TRP53 acts as a sensor of ribosomal integrity, and that
mutations in Rps19 and Rps20 can be phenotypically suppressed by
Trp53 deficiency [5]. Trp53 haploinsufficiency also relieves the
abnormal phenotypes of mice heterozygous for the sooty foot
ataxia allele of Rpl27a [7] or the Bst allele of Rpl24 [6]. Similarly,
our results show that loss of Rps7 increases TRP53 levels and that
Trp53 haploinsufficiency suppresses all morphological aspects of
the Rps7 phenotype. Our in vivo studies are supported by recent
studies showing that Rps7 depletion in vitro as well as in vivo in
zebrafish induces TRP53 expression [53,54], and collectively
suggest the mechanism underlying the Rps7 phenotype is TRP53
activation followed by TRP53-mediated apoptosis.
While these data suggest that RP mutant phenotypes may all be
attributed to alterations in RP—TRP53 interactions, the variabil-
ity among RP phenotypes suggests more complexity, potentially as
a result of RP gene-specific or cell-specific functions [55]. Tissue-
specific effects of mutations in different RPs have been observed in
zebrafish [4], mouse [5,6] and human [11]. These apparently
tissue-specific phenotypes could simply be due to incomplete
phenotypic characterization, differing severity of hypomorphic
alleles, and/or differing genetic backgrounds. However, if they
truly reflect tissue-specific RP functions, one explanation could be
differences in the relative expression levels of individual RPs, with
a consequent differential sensitivity to RP insufficiency that could
vary with tissue type, developmental stage or differentiation state.
Indeed, remarkable heterogeneity in RP mRNA levels has been
observed in a variety of tissues [56] including specifically during
mouse embryonic development [47] and human neuronal
differentiation [57].
A cell type-specific sensitivity to RP insufficiency is strongly
supported by the observation that keratinocyte-specific Rps6
hemizygosity causes hyperpigmentation while melanocyte-specific
Rps6 hemizygosity instead causes hypopigmentation [5]. Similarly,
the severe melanoblast reduction in Rps7 mutants could suggest a
melanocyte-specific sensitivity to RPS7 loss. Given that Sox10 and
Rps7 pathways interact in melanocytes in vivo (Figure S6, Figure
S7), it will be interesting to determine if a melanocyte-specific
transcriptional response to RPS7 deficiency is mediated by Sox10,
which is expressed in melanocytes but absent in keratinocytes.
TRP53 activation in melanocytes has already been associated with
downregulation of another white spotting gene, Kit, which is
proposed as a transcriptional target of TRP53 [7,58]. Further
work is needed in melanocytes and other cell types that display RP
gene-specific phenotypes, to clarify if direct transcriptional
regulation of lineage-specific genes plays a role in tissue-specific
sensitivity to individual RP deficiencies.
Another explanation of tissue-specific RP phenotypes could be a
function for individual RPs in the translation of specific mRNAs.
This is supported by studies of RPL13 [59] and by a recent study
reporting patterning defects in Rpl38 mutant mouse embryos due to
RPL38 translational regulation of a subset of Hox transcripts [47].
The tissue-specific phenotypes observed in Rps7 mutants would be
consistent with a role for RPS7 in facilitating translational
regulation of transcripts critical for development of the affected
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tissues. Alternatively, tissue-specific phenotypes observed in Rps7
mutants could be a consequence of a direct interaction between
RPS7 and tissue-specific developmental regulators at the protein
level. Interestingly, support for protein-protein interactions between
RPS7 and SOX10 comes from recent evidence that RPS7 interacts
directly with SRY, an HMG box protein related to SOX10 [60].
This mechanism of direct interaction between RPs and tissue-
specific, non-ribosomal proteins could explain tissue-specific phe-
notypes in RP mutants, and is supported by a number of studies
reporting extra-ribosomal functions of specific RPs in regulation of
ribosome biosynthesis and binding of transcription factor complexes
(reviewed in ref. [55]).
The relative contributions of these various mechanistic expla-
nations for tissue-specific and gene-specific RP mutant phenotypes
will be clarified with further detailed comparison of mutants on
consistent genetic backgrounds and with additional information
from tissue-specific conditional alleles. In summary, these novel
alleles of Rps7 add to the growing collection of mammalian
ribosomal mutants and provide two new mouse models of a DBA-
associated gene. Importantly, the unique CNS apoptosis and
behavioral phenotypes reported here suggest that RPs need to be
considered as candidate genes for not only DBA but also a broad
spectrum of neurodevelopmental human diseases.
Materials and Methods
Ethics statement
All procedures performed in the UK were in accordance with
the UK Animals (Scientific Procedures) Act 1986, and those
performed in the United States were approved by the IACUC in
accordance with NIH guidelines.
Mice
Montu mice were identified in a screen where BALB/c male mice
were mutagenized using ENU and crossed to C3H/He for
screening. Zuma mice were identified in an ENU screen sensitized
by Sox10 haploinsufficiency (Sox10LacZ/+), where BALB/cJ mice
were mutagenized using ENU and crossed to C57Bl/6J mice for
further pedigree analysis. Trp53 null mice (B6.129S2-Trp53tm1Tyj/J,
stock #002101) were purchased from JAX Mice. For behavioral
studies, mice were housed in facilities with a 12:12 light:dark cycle at
a temperature of 2261uC with a 60–70% humidity. Upon weaning,
mice were separated into single-sex littermate groups and food was
available ad libitum.
For body weight analysis, each gender/genotype group
represented in Figure 1B was weighed over 10 weeks (average
N = 9 for each Figure 1B data point, range N = 2–19). A Student’s
t-test was used to compare wild-type to mutant within gender-
matched groups at each age. Significance was assessed using the
Bonferonni method to correct for multiple testing, with p,0.001
deemed significant. In females, all time points after 1 week were
significantly different and in males all time points after 2 weeks
were significantly different, with the exception of 8.5 weeks where
only 2 mutant mice were weighed (p,0.003).
Alizarin red and alcian blue staining of skeletons was conducted
using standard techniques. Briefly, embryos were skinned and
eviscerated, fixed 24 hours in ethanol, then fixed 24 hours in
acetone. Staining was performed for 3–4 hours at 37uC and then
3–4 days at room temperature. After staining, embryos were
rinsed in water and cleared in 1% KOH for 3 hours at room
temperature and moved to fresh 1% KOH overnight. After
clearing, embryos were serially transferred through 20%/1%
KOH, 50% glycerol/1% KOH, and 80% glycerol/1% KOH.
FACS analysis was completed using standard techniques.
Briefly, fetal liver samples were collected in ice cold PBS and
dispersed into a single cell suspension with passage through a 21
gauge needle. Samples were incubated for 20 minutes with the
addition of 10 ml of each antibody (BD Parmingen Ter119-APC
and CD71-FITC), then washed once with PBS before FACS
analysis. At each age ANOVA analysis was performed with a post-
hoc test to compare selected pairs: (Rps7+/+ versus Rps7Zma/+) and
(Rps7Zma/+ versus Rps7Zma/+; Trp53KO/+).
Genetic mapping and sequencing
DNA was extracted from mice using standard techniques. For
Mtu, the mutation was mapped using 11 affected animals and 51
polymorphic MIT makers that were amplified by PCR and
visualized on a 4% agarose gel stained with ethidium bromide.
Fine mapping was performed with 13 additional SNPs that
distinguished between BALB/c and 101. Seventeen known and
predicted genes were identified in the Mtu critical interval from the
Ensembl database (ENSMUSG00000020633, ENSMUSG00
000066544, ENSMUSG00000020636, ENSMUSG00000036655,
ENSMUSG00000061477, ENSMUSG00000020630, ENSMU-
SG00000020629, ENSMUSG00000020628, ENSMUSG0000
0036613, ENSMUSG00000061911, ENSMUSG00000020674,
ENSMUSG00000020673, ENSMUSG00000020672, ENSMU-
SG00000043061, ENSMUSG00000044573, ENSMUSG00000
020669, ENSMUSG00000036136). All exons and adjacent splice
sites for these 17 genes were sequenced using a BigDye dideoxy-
terminator system and analyzed on an ABI3700 sequencer
(Applied Biosystems). For Zma, DNA from 8 offspring was
analyzed using the Illumina GoldenGate assay medium density
linkage panel (Illumina, San Diego, CA). The addition of 24
microsatellite markers, from 4 regions with suggestive linkage (Chr
4, 6, 12, 17) in 8 additional affected mice, allowed localization to
chromosome 12 (D12Mit182 -D12Mit60). Rps7 was sequenced as
a candidate gene using the same methods as for Mtu.
Cellular studies and Western blots
mRNA was extracted from wild-type and Rps7Mtu/+ brains, and
cDNA was prepared using reverse transcriptase (Invitrogen). A
high fidelity PCR polymerase (KOD, Novagen) was then
employed to amplify the Rps7 transcript encoding a fusion protein
tagged at either the C- or N-terminus with a FLAG epitope, prior
to cloning into the pcDNA3.1(+) vector. Constructs were
transfected into HeLa cells grown on glass coverslips, before
fixation and staining 48 hours later. The primary antibody
employed was a rabbit anti-FLAG (Abcam, ab21536, 1:1000),
followed by a fluorescent secondary (1:200, Molecular Probes).
Five independent transfections were performed. Images were
captured on a Zeiss LSM 510 confocal microscope.
For Western blot experiments, DNA constructs encoding wild-
type RPS7, RPS7 p.V156G, and RPS7 p.Y177S fused to the
FLAG epitope at the N- or C-terminus were used in transient
transfection experiments in human embryonic kidney (HEK) 293
cells. Neomycin phosphotransferase II (NPT2) expressed by the
cloning vector pcDNA3.1 was used as a control for transfection
efficiency. After transfection, proteins were separated on a 12%
SDS-PAGE, transferred onto a nitrocellulose Protran membrane
(Schleicher and Schuell) and incubated with a rabbit anti-FLAG
or anti-neomycin phosphotransferase II (NPT2) antibody for 1 hr.
Following three consecutive washes in PBS/Tween, the mem-
brane was incubated with horseradish peroxidase-conjugated goat
anti-rabbit Ab (Jackson Immunoresearch) and visualized using a
chemiluminescence detection kit (Pierce) and a LAS3000 Image
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System (Fuji). Equal loading was checked by Ponceau-S red
staining of the membranes before Western blot analysis.
Ribosomal analysis
For Northern blots for rRNA processing, RNA was extracted
from mouse tissues with Trizol (Invitrogen) according to the
manufacturer’s protocol. Total RNA was fractionated on formal-
dehyde-agarose gels and transferred to Gene Screen Plus
membrane (NEN). To detect rRNA precursor transcripts, ITS1
probe was prepared by 59 end-labeling of a 28-mer oligonucleotide
(GCTCCTCCACAGTCTCCCGTTAATGATC) with 25 mCi of
c [32P]-ATP and T4 polynucleotide kinase according to standard
protocols. Hybridization was carried out overnight at 42uC in 66
SSPE, 1% SDS, 0.25 mg/ml ssDNA and 56Denhardt’s solution.
After hybridization, the blot was washed twice with 1% SDS in 26
SSPE for 30 min at 37uC. Quantitation of signals was obtained by
phosphor screen scanning with a STORM PhosphorImager and
ImageQuant software analysis (Molecular Dynamics). The exper-
iments were performed on tissues from Rps7+/+ and Rps7Mtu/+
littermate mice (2 Rps7+/+ and 2 Rps7Mtu/+ for liver, 3 Rps7+/+
and 3 Rps7Mtu/+ for brain, each in triplicate). Quantitation is
reported as the ratio between 30S and 21S rRNA precursors and
was significantly different between genotypes in both brain
(p,0.01) and liver (p,0.01) (two-way ANOVA with post hoc t-
test).
For ribosome isolation, cytoplasmic extracts from RPS7
p.V156G transiently transfected HEK-293 cells were fractionated
through ultracentrifugation on a sucrose cushion. After 2 hours of
centrifugation at 100,000 g, ribosomes and ribosomal subunits
were recovered in the pellet and free cytoplasmic proteins were
recovered from the supernatant.
For sucrose gradients separating polysomes and ribosomal
subunits, cytoplasmic extracts from Mtu/+ liver were loaded onto a
10%–30% linear sucrose gradient containing 30 mM Tris-HCl
(pH 7.5), 100 mM NaCl, and 10 mM MgCl2. Gradients were
centrifuged in a Beckman SW 41 rotor for 5 hr at 37,000 rpm and
then the absorbance profile of the gradient was used to evaluate
the ratio between the peaks of ribosomal subunits (60S and 40S).
In situ hybridization
For whole mount, Pmel17-containing plasmid (Riken cDNA
clone G370069C13; GenBank Acc: BB766987) was digested with
Kpn1 and transcribed with T3 polymerase to generate DIG-
labeled in situ probes. Hybridizations were performed using
published protocols [61] with the following modifications. After
probe hybridization, Ribonuclease A digestion was omitted, and
Tris-buffered saline was used in place of PBS. BM-purple substrate
(Roche, Molecular Biochemicals) was used in place of 5-bromo-4-
chloro-3-indolyl phosphate/nitroblue tetrazolium. Embryos were
photographed using a Zeiss SteREO Discovery V12 microscope
with a Zeiss AxioCam camera. Probes to detect Rps7 by in situ
hybridization were amplified by PCR and cloned into the pCRII-
TOPO vector (Invitrogen) using the following primer pairs:
R7_IN_F AAGGAAATCGAAGTTGGTG and R7_IN_ R
AATTAACATCCTTGCCTGTG. Mouse embryos were fixed
in 2–4% (w/v) paraformaldehyde, cryoprotected with 30% (w/v)
sucrose in phosphate buffer before sectioning (10–20 mm) on a
cryostat. In situ hybridization was carried out as previously
described [62]. Briefly, hybridization of sections with 35S-UTP-
labeled RNA probes was carried out in a 50% (v/v) formamide
solution at 60uC. Sections were washed in 50% (v/v) formamide,
an RNAse A treatment was performed for 30 min at 37uC, and
then successively stringent SSC solution washes were performed,
with a final wash at 0.16 SSC at 60uC.
Histology and immunohistochemistry
For Nissl staining, adult mice were perfused with 0.9% NaCl
and 4% (w/v) paraformaldehyde before the brain was dehydrated
in 30% sucrose, sectioned (40 mm) on a freezing microtome, and
stained.. For embryonic histology, embryos were fixed in either
Bouin’s fixative or 4% paraformaldehyde overnight, washed
extensively in PBS, and dehydrated in 70% ethanol before
sectioning (5–7 mm paraffin) and hematoxylin and eosin (H and E)
staining. For immunohistochemistry, embryos were fixed in 4%
paraformaldehyde overnight, washed with PBS, dehydrated in
10% sucrose followed by 20% sucrose, then embedded in Neg-50
(Thermo Scientific) for cryosectioning (14 mm). Antibodies includ-
ed anti-TRP53 (Leica NCL-p53-CM5p, 1:200), anti-CC3 (Cell
Signaling #9661, 1:200), and anti-PH3 (Millipore #06-570,
1:200) and resulting stains were imaged using a Zeiss Observer.D1
microscope. For apoptosis and proliferation experiments, trans-
verse cryo-sections collected at the level of the forelimb from 3
embryos of each genotype, 6 sections per embryo, were counted
for CC3+ and PH3+ cells. InStat software (GraphPad Software,
Inc.) was used for one-way ANOVA statistical analysis. No
significant difference among the three genotypes was observed in
PH3+ cell counts (p = 0.902). CC3 counts were significantly
different among genotypes (p = 0.0005) and a Tukey-Kramer
multiple comparison post test was used for pairwise comparison
among all genotypes with the following results: Rps7+/+ versus
Rps7Zma/+ (p,0.001), Rps7+/+ versus Rps7Zma/+; Trp53KO/+
(P.0.05, no significant difference), Rps7Zma/+ versus Rps7Zma/+;
Trp53KO/+ (p,0.01).
Behavioral phenotyping
Behavioral phenotyping was performed on mutant and unaf-
fected sex-matched littermates between 8 and 12 weeks of age.
Open-field tests were conducted for 5 minutes in a brightly lit,
60 cm diameter, enclosed white arena (field), and monitored by an
automated tracking system to measure the total distance travelled
and the amount of time spent in the center versus the border of the
field. The elevated plus maze test was conducted with an elevated
platform consisting of two enclosed arms and two open arms. An
automated tracking system was employed to measure the number
of entries into each arm and distance traveled in open and closed
arms of the elevated plus maze over 5 minutes. Spontaneous
alternation was performed in an enclosed T-maze built from gray
plastic (arm dimensions 30 cm610 cm630 cm). Each mouse
underwent 10 trials with an inter-trial interval of at least
20 minutes. For each trial the mouse was placed in the start
arm facing the end wall and allowed to enter a goal arm of its own
choice. The mouse was confined in the goal arm for 30 seconds
and then put back in the start arm and allowed a free choice of
either arm [31].
MRM imaging
Late gestation (E18.5) embryos were collected, fixed in 4%
paraformaldehyde overnight, washed extensively in PBS, and
stored in 70% ethanol. Prior to imaging, embryos were rehydrated
in a solution of PBS and 0.5% (v/v) Magnevist (Bayer Healthcare
Pharmaceuticals, Wayne, NJ), a contrast agent. MRM was
performed on specimens using a Bruker 14.1T MR imaging
spectrometer (Bruker Biospin, Billerica, MA) using a multi-echo
RARE technique [63] with TR/TE = 200/6.9 ms, 8-echoes, and
4 signal averages. The resulting 3D images were acquired in
53 min with an acquisition resolution of 50 microns isotropic.
Manual segmentation of the whole brain and 10 major anatomical
regions was performed using Amira visualization software (v5.2.2,
Visage Imaging Inc., Andover MA, USA) with guidance from an
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anatomical reference atlas [64]. The volume of these regions was
estimated and 3D rendering with smoothing was performed to
generate 3D representations. Student’s t-tests were used to
compare volumes of each Rps7+/+ and Rps7Zma/+ brain region.
Significance was assessed using the Bonferonni method to correct
for multiple testing, with p,0.005 deemed significant.
Supporting Information
Figure S1 Montu and zuma map to mouse Chromosome 12 and
cause a variety of phenotypes. (A,B) Genotyping data for montu
(Mtu, A) and Zuma (Zma, B) mapping. Black boxes represent
heterozygous genotypes and white boxes represent homozygous
wild-type genotypes. Marker names are listed at left and the
number of mice in each genotype category is shown beneath each
column. Double-headed arrows at right indicate the critical
interval that flanked a non-recombinant marker. (C) The Mtu and
Zma critical intervals, markers used for mapping, and relevant map
intervals on mouse Chromosome 12 are indicated. Coordinates
are based on NCBI Build 34. (D) Results from an Rps7Mtu6Rps7Zma
intercross showed that Rps7Mtu and Rps7Zma do not complement
each other and are therefore alleles of the same gene.
(TIF)
Figure S2 Evolutionary conservation of RPS7 and predicted
structural effects of Rps7Mtu (p.V156G) and Rps7Zma (p.Y177S)
mutations. (A) The amino acid residues altered by the Rps7Mtu and
Rps7Zma mutations are highly conserved across a wide range of
species. Green highlight indicates the location of p.V156 and
p.Y177, and red font indicates non-identical residues. (B)
Alignments of secondary structure predictions indicate that the
Rps7Mtu and Rps7Zma mouse alleles cause no gross structural
changes in RPS7 as a result of the encoded amino acid alterations.
The experimentally determined secondary structures of yeast (S.
cerevisiae) and tetrahymena (T. thermophila) RPS7 orthologs (PDB ID
3U5C and PDB ID 2XZM, respectively) are aligned with
secondary structure predictions of the S. cerevisiae, T. thermophila,
and mouse RPS7, RPS7Mtu and Rps7Zma proteins (generated with
both PSSpred and PROFsec). In the predictions, numbers indicate
reliability scores ranging from low (0) to high (9). Residues
predicted as helix and strand are highlighted in blue and gray,
respectively. (C) The 3-dimensional structure of the yeast 80S
ribosomal subunit [21]. Color-coding is as follows: RPS7, red; 60S
subunit proteins, cyan; 40S subunit proteins, purple; and rRNA,
gray. The position of residues homologous to mouse p.V156 and
p.Y177 are highlighted in green. (D) Closer view of the RPS7-
containing region of the 80S side view shown in panel C.
(TIF)
Figure S3 Mutant RPS7 is assembled into ribosomes. (A)
Western blot showing similar levels of expression for N- and C-
terminal FLAG tagged wild-type RPS7 (WT N and WT C,
respectively) and RPS7Zma (MUT N and C, respectively) in HEK-
293 cells. NPT2 expression is shown as a control to normalize for
transfection efficiency. (B) Cytoplasmic extracts from transiently
transfected HEK-293 cells were fractionated. A similar fraction of
all transfected RPS7 proteins is observed in the ribosomal pellet (P)
compared to the supernatant (S). (C) Polysomal profiles of liver
cytoplasmic extracts. After ultracentrifugation, the Optical Density
at 260 nm was measured along the sucrose gradient. Ratio
between 60S and 40S peaks in Rps7Mtu/+ is similar to control. The
slight variation in 80S peak relative height is not significant as it is
within the variability observed between samples, independent of
genotype.
(TIF)
Figure S4 Embryonic developmental delay in Rps7Zma/+ mice is
suppressed by Trp53 deficiency. Chronologically age-matched
littermate embryos illustrate that Rps7Zma/+ mice exhibit devel-
opmental delay at E11.5 and E12.5 relative to Rps7+/+ littermates
(left 4 panels). This Rps7Zma-associated developmental delay is
suppressed by Trp53 deficiency in Rps7Zma/+; Trp53KO/+ (right 4
panels). Images for each of the 4 genotypes are shown at the same
magnification within an age (row).
(TIF)
Figure S5 Pmel17 expression is reduced at E12.5 in Rps7 mutant
embryos. Comparison of Pmel17 in situ hybridizations of E12.5
Rps7Zma/+ embryos (middle 3 panels) with E12.5 Rps7+/+
embryos (left 3 panels) showed that Rps7Zma/+ embryos exhibit a
severe reduction in melanoblasts. Furthermore, melanoblast
number in E12.5 Rps7Zma/+ embryos was reduced below that of
E11.5 Rps7+/+ embryos (right 3 panels), thus showing that the
melanoblast reduction in Rps7Zma/+ embryos exceeds the gross
developmental delay observed in Rps7Zma/+ mutants. This
reduction is especially evident from comparison of E12.5
Rps7Zma/+ and E11.5 Rps7+/+ melanoblast populations in the
otic area (arrows), in the trunk posterior to the forelimb (*), and in
the tail region (arrowheads). Scale bars = 1 mm.
(TIF)
Figure S6 Mutation of Rps7 and Sox10 act synergistically to
reduce melanoblast number. Combined haploinsufficiency for
Rps7 and Sox10 (Rps7Zma/+; Sox10LacZ/+ double heterozygotes)
greatly reduced melanoblast number at E12.5 (middle 3 panels)
as compared to E12.5 Rps7+/+; Sox10LacZ/+mice (left 3 panels).
Furthermore, E12.5 Rps7Zma/+; Sox10LacZ/+ mice showed a
greater reduction in melanoblast number in comparison with
E11.5 Rps7+/+; Sox10LacZ/+ mice, indicating that this reduction
in melanoblasts exceeded the gross developmental delay observed
in Rps7Zma/+ mutants. Reduction is especially evident in
melanoblast populations in the otic area (arrow), and in the tail
region posterior to the hindlimb (arrowhead and posterior). Scale
bars = 1 mm.
(TIF)
Figure S7 Rps7 mutation increases Sox10-dependent hypopig-
mentation and does not result in dark skin. (A, B) Rps7Zma/+;
Sox10LacZ/+ double mutants that survive postnatally exhibit
more extensive hypopigmentation than Rps7Zma/+or Sox10-
LacZ/+ mutants. A representative Rps7Zma/+; Sox10LacZ/+ mouse
is shown (A) along with quantitative scoring (0 = no spotting;
4 = the largest ventral spots that extend to the dorsal surface)
comparing the white spotting in Rps7+/+; Sox10LacZ/+ (blue,
N = 27), Rps7Zma/+; Sox10+/+ (red, N = 16), and Rps7Zma/+;
Sox10LacZ/+ (yellow, N = 8) (B). (C, D) Adult Rps7 mutants do
not have dark skin in foot pads and tails. (E,F) H&E stained
sections through the tail skin of Rps7Zma/+ mice reveal
epidermal (*) and dermal (arrowhead) pigmentation similar to
that of Rps7+/+ mice, confirming the presence of melanocytes
in the tail.
(TIF)
Figure S8 Behavioral assessment of Rps7Mtu/+ mutants. (A)
Total distance traveled in the open-field test by Rps7+/+ controls
(WT) and Rps7Mtu/+ (Mtu) (N = 11) was similar (p = 0.5). (B–E)
Likewise there were no significant differences between Rps7+/+
and Rps7Mtu/+ on the elevated plus maze. Open arm distance (B,
P.0.5), open arm entries (C, P.0.5), closed arm distance (D,
P.0.5), and closed arm entries (E, P.0.1) were all comparable
(N = 11).
(TIF)
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Figure S9 Rps7 mutants have pyknotic nuclei in the spinal cord.
H&E stained sagittal sections through the spinal cord of E18.5
Rps7+/+ (A, B) and Rps7Zma/+ (C, D) embryos. Arrow in D indicates
an example of a darkly stained, condensed nucleus characteristic of
pyknotic nuclei observed throughout the Rps7Zma/+ spinal cord.
Anterior is oriented towards the top and posterior to the bottom of
all images. Boxed regions in A, C define the respective areas shown
at higher magnification in B, D. Abbreviations: vertebral column
(V), spinal cord (SC). Scale bars = 100 mm.
(TIF)
Figure S10 Rps7 mRNA expression pattern. Mouse Rps7
transcript was detected by in situ hybridization at E13.5 (A, E),
E16.5 (B, F), E17.5 (D), and adulthood (C, G). Broad expression
was detected in the developing embryo, including a high level of
expression in the ganglionic eminences (arrowhead in D), the
proliferative ventricular zone (E), as well as in the dentate gyrus on
the hippocampus in adult animals (G). Abbreviations: ventricular
zone/subventricular zone (VZ/SVZ), intermediate zone (IZ),
cortical plate (CP), CA3 region of hippocampus (CA3), dentate
gyrus (DG).
(TIF)
Figure S11 Rps7 mutants have increased TRP53 expression. (A–
C) Increased TRP53 expression was detected in E11.5 Rps7Zma/+
(Z/+) coronal sections through the neocortex compared to Rps7+/
+ (+/+) and Rps7Zma/+; Trp53KO/+ (Z/+;p53/+). (D–I) This
increase was also detected in the neural tube of Rps7Zma/+
embryos at E11.5 (D–F) and E12.5 (G–I). Scale bars = 100 mm.
(TIF)
Table S1 Circulating blood counts from+/+and Rps7Mtu/+ adult
male mice.
(PDF)
Table S2 Biochemical panel from+/+and Rps7Mtu/+ adult male
mice.
(PDF)
Table S3 Rps7Zma/+ erythrocytes are able to terminally
differentiate, but they display modest developmental delay that is
suppressed by Trp53 haploinsufficiency.
(PDF)
Table S4 Surviving numbers of postnatal offspring from an
Rps7Zma/+; Trp53+/26C57BL/6J cross demonstrate that Trp53
haploinsufficiency restores Rps7 viability.
(PDF)
Video S1 MRM-based reconstructions of Rps7+/+ brain.
Regions of late gestation (E18.5) brain defined by manual
segmentation of MRM images for volumetric calculations are
shown as follows: olfactory bulbs (light gray), lateral ventricles (lime
green), cortex (red), septum (yellow), striatum (dark blue), 4th
ventricle (charcoal gray), hippocampus (purple), thalamus (cyan),
colliculi (orange), cerebellum (dark green).
(MOV)
Video S2 MRM-based reconstructions of Rps7Zma/+ brain.
Regions of late gestation (E18.5) brain defined by manual
segmentation of MRM images for volumetric calculations are
shown as follows: olfactory bulbs (light gray), lateral ventricles (lime
green), cortex (red), septum (yellow), striatum (dark blue), 4th
ventricle (charcoal gray), hippocampus (purple), thalamus (cyan),
colliculi (orange), cerebellum (dark green).
(MOV)
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